effect overlay
activetrials
Epilepsy
Epilepsy
Epi-Minder

A Prospective Study To Assess The Safety Of A Sub-Scalp Monitoring Device For The Recording Of Brain Electrical Activity Associated With The Occurrence Of Epileptic Seizures
 

HREC: 2022.246
Principal Investigator: Dr John-Paul Nicolo
Coordinator contact: Sean Hosking
Funding: Non-Commercial
Epilepsy
Epilepsy
RENAISSANCE Study

A Phase 2, Multicenter, Open Label Safety and Tolerability Study of SPN-817 in Adult Patients with Treatment Resistant Epilepsy
 

HREC: 2022.261
Principal Investigator: Dr John-Paul Nicolo
Coordinator contact: Sean Hosking
Funding: Commercial
Epilepsy
Epilepsy
Xenon 301

A Randomized, Double-blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures
 

HREC: 2023.062
Principal Investigator: Dr John-Paul Nicolo
Coordinator contact: Karen Chidgey
Funding: Commercial
Epilepsy
Epilepsy
Xenon 303

A Randomized, Double-blind, Placebo-Controlled, Multicenter, Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
 

HREC: 2023.063
Principal Investigator: Dr John-Paul Nicolo
Coordinator contact: Karen Chidgey
Funding: Commercial
Epilepsy
Epilepsy
Xenon 304

A Multicenter, Open-label, Long-term, Safety, Tolerability, and Efficacy Study of XEN1101 in Adults Diagnosed With Epilepsy
 

HREC: 2023.064
Principal Investigator: Dr John-Paul Nicolo
Coordinator contact: Karen Chidgey
Funding: Commercial